FDA Inspection 1094007 — DeGowin Blood Center

DeGowin Blood Center — FEI 1972918

The FDA completed an inspection of DeGowin Blood Center on June 6, 2019 in Iowa City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 6, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Iowa City, IA (United States)